SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq:
SQNM) today announced that a live audio webcast and accompanying slide
presentation will be provided for its analyst and investor briefing event
"Sequenom: The Future of Noninvasive Prenatal Diagnostics." Details of the
event are as follows:
What: Sequenom: The Future of Noninvasive Prenatal Diagnostics
When: Tuesday, June 3, 2008 at 6:00 p.m. Pacific time
Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc.
Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine
Brown University Medical School
"Methods for screening pregnancies for Down syndrome"
Allan T. Bombard, MD, FACOG, FACS, FACMG, Chief Medical Officer, Sharp
Mary Birch Hospital; Adjunct Professor, Obstetrics and Gynecology/SUNY
Downstate Medical Center; Clinical Professor, Albert Einstein College of
"Current clinical practice for Down syndrome screening and diagnosis"
Betty Dragon, Ph.D., Senior Vice President, Research & Development of
"Sequenom's SEQureDx: A noninvasive prenatal diagnostic test for Down
syndrome. Technical Achievements, Milestones and Future Challenges"
Dennis Lo, Consultant to Sequenom, Inc.
"The future of prenatal diagnosis: Progress through fetal nucleic acids"
How: Live over the Internet - Simply log on to the web at the address
above. Presentation will be archived.
Contact: Lippert/Heilshorn & Associates
Jody Cain (firstname.lastname@example.org)
Sequenom is committed to providing the best genetic analysis products
for research and the molecular diagnostic markets. The Company m
|SOURCE Sequenom, Inc.|
Copyright©2008 PR Newswire.
All rights reserved